kapsułki dojelitowe

DRUG2 trials

Sponsors

Medical University Of Warsaw, Instytut Psychiatrii I Neurologii

Conditions

Crohn's diseaseNeurodegeneration with brain iron accumulation (NBIA)including pantothenate kinase-associated neurodegeneration (PKAN) and mitochondrial membrane protein-associated neurodegeneration (MPAN).

Phase 2

Phase 2, randomized, blinded, non-treatment-controlled study assessing the efficacy and safety of dimethyl fumarate in patients with NBIA, a neurodegeneration associated with brain iron accumulation.

WithdrawnCTIS2026-525990-38-00

Instytut Psychiatrii I NeurologiiNeurodegeneration with brain iron accumulation (NBIA), including pantothenate kinase-associated neurodegeneration (PKAN) and mitochondrial membrane protein-associated neurodegeneration (MPAN).

Target: 40Updated: 2026-09-07

Phase 3

Evaluation of the efficacy of topical treatment with budesonide in children with Crohn's disease located in the esophagus and/or stomach and/or duodenum - BETHESDa

RecruitingCTIS2024-519269-23-00

Medical University Of WarsawCrohn's disease

Start: 2024-03-27Target: 138Updated: 2025-07-10